Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
The Treatment of Tuberculosis in HIV-Infected Patients
This study has been completed.
Study NCT00001033 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: November 2, 1999 Last Updated: August 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Tuberculosis
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mycobacterium Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Ethambutol hydrochloride
Isoniazid
Pyrazinamide
Pyridoxine hydrochloride
Levofloxacin
Rifampin
Additional drug interventions recognized in this trial
Ethambutol
Ofloxacin
Pyridoxal
Pyridoxine
Vitamin B 6
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antibiotics, Antitubercular
Antilipemic Agents
Antimetabolites
Antitubercular Agents
Enzyme Inhibitors
Fatty Acid Synthesis Inhibitors
Growth Substances
Leprostatic Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content